Several lines of evidence indicate that glutamate plays a crucial role in the initiation of seizures and their propagation; abnormal glutamate release causes synchronous firing of large populations of neurons, leading to seizures. In the present study, we investigated whether enhanced glutamate uptake by increased glial glutamate transporter EAAT2, the major glutamate transporter, could prevent seizure activity and reduce epileptogenic processes. EAAT2 transgenic mice, which have a 1.5-2 fold increase in EAAT2 protein levels as compared to their non-transgenic counterparts, were tested in a pilocarpine-induced status epilepticus (SE) model. Several striking phenomena were observed in EAAT2 transgenic mice compared with their nontransgenic littermates. First, the post-SE mortality rate and chronic seizure frequency were significantly decreased. Second, neuronal degeneration in hippocampal subfields after SE were significantly reduced. Third, the SE-induced neurogenesis and mossy fiber sprouting were significantly decreased. The severity of cell loss in epileptic mice was positively correlated with that of mossy fiber sprouting and chronic seizure frequency. Our results suggest that increased EAAT2 expression can protect mice against SE-induced death, neuropathological changes, and chronic seizure development. This study suggests that enhancing EAAT2 protein expression is a potential therapeutic approach.
Introduction
Epilepsy is one of the most frequent neurological disorders (Strine et al., 2005) . Over 40 types of epilepsies have been identified and classified into two categories: partial epilepsies and generalized epilepsies (Engel, 2001) . Partial epilepsies account for about 60% of all adult cases while temporal lobe epilepsy (TLE) is the most common form of partial epilepsy causing refractory epilepsy (Wiebe, 2000) . TLE is characterized by spontaneous recurrent motor seizures (SRSs) originating from temporal lobe foci. Patients with TLE often show impairments in learning, memory, and other cognitive functions (Devinsky, 2004) . TLE is usually preceded by an initial precipitating injury such as status epilepticus (SE), head trauma, childhood febrile seizures, or hypoxia (Acharya et al., 2008) . There is commonly a latent period of several years between the initial injury and the emergence of chronic TLE. The initial injury is thought to cause complex molecular, biochemical, and structural changes that, over time, result in the development of SRSs. This process is referred to as epileptogenesis (McNamara et al., 2006) .
Among the events that occur in response to the initial injury, neuronal death is believed to be an important propagating factor that links the initial injury with the epileptic condition. Neuronal death may be both a cause, as well as a consequence, of epileptic seizures. The intense seizure activity associated with SE can cause significant neurodegeneration in the hippocampus regions CA1, CA3, and dentate hilus (Rao et al., 2006; Sloviter, 1999; Sloviter and Dempster, 1985) . This neuronal loss is most likely secondary to sustained excitation and subsequent glutamate-mediated excitotoxicity.
Glutamate plays a crucial role in the initiation and propagation of seizures. In vivo microdialysis studies of patients with epilepsy show a sustained increase in extracellular glutamate levels, which reach neurotoxic concentrations in the epileptogenic hippocampus before and during seizure onset (Cavus et al., 2005; During and Spencer, 1993) . Abnormal enhanced glutamate released by astrocytes is considered a causal role in the synchronous firing of large populations of neurons during seizures (Benarroch, 2009; Binder and Steinhauser, 2006; Tian et al., 2005; Wetherington et al., 2008) . Additionally, dysfunction of glutamate transport may contribute to high extracellular glutamate in the epileptogenic hippocampus. Impaired glutamate transport function has been reported in human epilepsy, but remains controversial (Bjornsen et al., 2007; Mathern et al., 1999; Proper et al., 2002; Sarac et al., 2009; Tessler et al., 1999) . Therefore, reduction of glutamate-mediated excitotoxicity is a potential strategy to prevent seizure-induced neuronal death and subsequent recurrent seizures. 
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